Improving Self Management Skills of Older Adults With Diabetes
- Conditions
- DiabetesType 2 Diabetes
- Interventions
- Behavioral: Diabetes Self Management Program
- Registration Number
- NCT01943357
- Lead Sponsor
- Stanford University
- Brief Summary
The study will help determine if the Better Choices Better Health Diabetes program (community-based or online, also known as the Diabetes Self-Management Program) improves the hbA1C of people with Type-II diabetes. The investigators will also examine 1) symptoms (fatigue, sleep, low blood sugar symptoms, depression, shortness of breath), 2) healthy behaviors (blood sugar monitoring; taking medications as prescribed; getting eye, foot, kidney and cholesterol exams; and activity), 3) the use of health care services. This project is a translational study to demonstrate the effectiveness of the intervention in the context of a major insurer.
- Detailed Description
Self-report questionnaires and hbA1c capillary blood collection kits will be administered at baseline (prior to the intervention), six-months and twelve-months. Differences between baseline and followup scores will be used to determine if participants have benefited from the intervention, using intent-to-treat methodology. Subgroups and delivery method (small-group or on-line) will be compared using repeated measures and analyses of covariance.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1000
- type 2 diabetes
- WellPoint insurance or medicare supplement plan participant
- 18 years or older
- Treatment for cancer in past year
- Pregnant
- Under 18
- Previously taken a Stanford self-management program
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Diabetes Self-Management Program Diabetes Self Management Program Behavioral: Diabetes Self Management Program. Consists of either a six-week small-group face-to-face program with two peer leaders or an six-week peer-facilitated Internet-based program.
- Primary Outcome Measures
Name Time Method Metabolic control HbA1C Baseline to 12 months
- Secondary Outcome Measures
Name Time Method Symptom:fatigue Baseline to 12 months Single item visual numeric scale. Examined at baseline, 6 months and 12 months. Paired t-tests used to assess if change significant.
symptom: sleep Baseline to 12 months Single item visual numeric scale. Examined at baseline, 6 months and 12 months. Paired t-tests used to assess if change significant.
symptom: PHQ-8 depression Baseline to 12 months 8-item scale. Examined at baseline, 6 months and 12 months. Paired t-tests used to assess if any changes are significant.
symptoms: hypoglycemic index Baseline to 12 months 7-item scale. Examined at baseline, 6 months and 12 months. Paired t-tests used to assess if any changes are significant.
health behavior: blood glucose monitoring Baseline to 12 months Self report of how often monitor glucose at baseline, 6 months and 12 months. Paired t-tests used to assess if any changes are significant.
health behavior: medication adherence baseline to 12 months 3-item scale collected at baseline, 6 months and 12 months. Paired t-tests used to assess if any changes are significant.
Health behavior: communication with physician baseline to 12 months 3-item scale collected at baseline, 6 months and 12 months. Paired t-tests used to assess if any changes are significant.
health behavior: exercise baseline to 12 months Minutes of exercise during last week self-reported at baseline, 6-months and 12-months. Paired t-tests used to assess if any changes are significant.
health behavior/utilization: frequency of exams baseline to 12 months Self report of how often examine feet and have eye, cholesterol and kidney levels tested. Collected at baseline, 6 months and 12 months. Paired t-tests used to assess if any changes are significant.
Health care utilization baseline to 12 months Physician, ED, hospital visits in last six-months. Self reported at baseline, 6 months and 12 months. Paired t-tests used to assess if any changes are significant.
Trial Locations
- Locations (1)
Stanford University School of Medicine
🇺🇸Stanford, California, United States